Javier “Jave” Castillo, R.Ph, Vice President, CSO Strategy, IQVIA
Advertisement
Articles by Javier “Jave” Castillo, R.Ph, Vice President, CSO Strategy, IQVIA
Brand Insights - Thought Leadership | Paid Program
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Parabilis Reaches $3.7 Billion Market Cap on Frist Day Listed on NASDAQ
2
How Basket-Trials are Reshaping Drug Development Timelines
3
The New Capital of Care in Rare Disease
4
Pharmaceutical Executive Daily: Parabilis Medicines Prices Record-Breaking $670 Million IPO
5